Definitive Healthcare Corp. (DH) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DH Revenue Growth
Revenue Breakdown (FY 2025)
DH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
DH Revenue Analysis (2019–2025)
As of May 8, 2026, Definitive Healthcare Corp. (DH) generated trailing twelve-month (TTM) revenue of $238.3 million, reflecting moderate decline in growth of -5.5% year-over-year. The most recent quarter (Q1 2026) recorded $55.9 million in revenue, down 9.1% sequentially.
Looking at the longer-term picture, DH's 5-year compound annual growth rate (CAGR) stands at +15.3%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $252.2 million in 2024.
Revenue diversification analysis shows DH's business is primarily driven by Subscription Services (96%), and Professional Services (4%). With over half of revenue concentrated in Subscription Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including VEEV (+16.3% YoY), MMSI (+11.2% YoY), and DOCS (+15.9% YoY), DH has underperformed the peer group in terms of revenue growth. Compare DH vs VEEV →
DH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DHCurrent | $238M | -5.5% | +15.3% | -8.5% | |
 VEEV | $3.2B | +16.3% | +16.9% | 28.7% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% | |
 DOCS | $570M | +15.9% | +37.4% | 39.9% | |
 HCAT | $311M | +1.5% | +10.5% | -51.7% | |
 PINC | $1.0B | -16.2% | -4.9% | 0.1% |
DH Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $241.5M | -4.2% | $183.3M | 75.9% | $-20,583,000 | -8.5% |
| 2024 | $252.2M | +0.3% | $197.5M | 78.3% | $-710,820,000 | -281.8% |
| 2023 | $251.4M | +12.9% | $203.9M | 81.1% | $-329,800,000 | -131.2% |
| 2022 | $222.7M | +34.0% | $180.0M | 80.9% | $-44,043,000 | -19.8% |
| 2021 | $166.2M | +40.4% | $125.5M | 75.5% | $-27,317,000 | -16.4% |
| 2020 | $118.3M | +38.4% | $87.8M | 74.2% | $-15,886,000 | -13.4% |
| 2019 | $85.5M | - | $42.5M | 49.7% | $-2,175,000 | -2.5% |
See DH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDH — Frequently Asked Questions
Quick answers to the most common questions about buying DH stock.
Is DH's revenue growth accelerating or slowing?
DH revenue declined -5.5% year-over-year, contrasting with the 5-year CAGR of +15.3%. TTM revenue fell to $238M. This reverses the prior growth trend.
What is DH's long-term revenue growth rate?
Definitive Healthcare Corp.'s 5-year revenue CAGR of +15.3% reflects the variable expansion pattern. Current YoY growth of -5.5% is below this long-term average.
How is DH's revenue distributed by segment?
DH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.